Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jan 29
Love0

Reducing Administrative Burden in Dermatology Through Compounding Alternatives

By Chuck Lin No Comments
Letter to the Editor: Administrative burdens, particularly prior authorization (PA) requirements and appeals, remain a significant barrier to timely dermatologic care. On average, physicians complete 39 PAs per week, dedicating…
Read More
Jan 29
Love0

Real-World Effectiveness of Lebrikizumab for the Prurigo Nodularis–Like Phenotype of Atopic Dermatitis: A One-Year Retrospective Study

By Chuck Lin No Comments
To the Editor: Atopic dermatitis (AD) presents with several phenotypes, among which the prurigo nodularis (PN)-like phenotype is particularly resistant to treatment.1 PN-like phenotype of AD is characterized by multiple…
Read More
Jan 29
Love0

The Senile Cell: Understanding Cellular Senescence in Dermatology

By Chuck Lin No Comments
INTRODUCTIONCellular senescence is a permanent and stable arrest of the cell cycle triggered by endogenous and exogenous stressors, such as DNA damage, oxidative stress, and telomere dysfunction.1,2 In this state,…
Read More
Jan 29
Love0

Reddit Discourse on Eczema: Quantitative Analysis of Misinformation, Engagement, and Alignment With 2025 American Academy of Dermatology Guidelines

By Chuck Lin No Comments
INTRODUCTIONAopic dermatitis (AD) is a chronic inflammatory disease with significant psychosocial burden.¹ Patients increasingly seek dermatological information and guidance on Reddit, a platform with over 70 million daily active users,…
Read More
Jan 29
Love0

Treatment of Generalized Granuloma Annulare With Biologics and Oral JAK Inhibitors: A Case Series

By Chuck Lin No Comments
INTRODUCTIONGranuloma annulare (GA) is a granulomatous inflammatory skin condition of unknown etiology, often presenting as annular plaques or papules.1 Generalized GA (GGA) is a rare subtype of GA characterized by…
Read More
Jan 26
Love0

Clinical Efficacy of Second-Generation Tetracyclines as First-Line Systemic Agents for Gingival Lichen Planus

By Chuck Lin No Comments
INTRODUCTIONOral lichen planus (OLP) is a common, chronic mucosal inflammatory disease associated with T-cell-mediated immunologic dysfunction.1 Although the buccal mucosa and tongue are the most frequent sites of involvement, gingival…
Read More
Jan 26
Love0

A Systematic Evaluation of Mpox Public Health Educational Resources

By Chuck Lin No Comments
INTRODUCTIONMpox (formerly known as monkeypox), a zoonotic orthopoxvirus related to smallpox, was first identified in humans in the Democratic Republic of the Congo in 1970 and was historically endemic to…
Read More
Jan 16
Love0

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

By Chuck Lin No Comments
INTRODUCTIONRetrospective analyses of clinical trial research over the last two decades have revealed that minority enrollment is lacking across all medical specialties, and efforts to increase representation have historically been…
Read More
Jan 15
Love0

Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy

By Chuck Lin No Comments
INTRODUCTIONDominant dystrophic epidermolysis bullosa (DDEB) is a hereditary genetic disorder with a mutation of the type VII collagen gene (COL7A1), resulting in a defect of anchoring collagen VII (Col VII),…
Read More
Jan 15
Love0

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

By Chuck Lin No Comments
INTRODUCTIONAcrodermatitis continua of Hallopeau (ACH) is a rare, localized variant of pustular psoriasis. Fewer than 200 cases have been reported in the literature. It is characterized by recurrent, tender, sterile…
Read More
Jan 01
Love0

Prospective Single-Site Open-label Study Assessing Safety and Efficacy of Poly-L-Lactic Acid for Temple Volume Loss

By Chuck Lin No Comments
INTRODUCTIONThe aging process is complex, influenced by a dynamic interplay of external (lifestyle and environment) and internal (genetics) factors. Changes such as bone resorption, fat pad depletion, muscle atrophy, and…
Read More
Jan 01
Love0

Prevalence of Pruritus in Type 2 Diabetic Patients on GLP-1 Agonist Therapy

By Chuck Lin No Comments
INTRODUCTIONChronic pruritus is a commonly underestimated comorbidity in type 2 diabetes mellitus (T2DM) patients, affecting between 18.4% to 27.5% of diabetics.1 Glucagon-like peptide-1 (GLP-1) agonists have reportedly decreased itch in…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments January 30, 2026
  • JDD Re:View With Dr. Beer January 29, 2026
  • Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome January 28, 2026
  • Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab January 26, 2026
  • Oncoderm Resource Center January 23, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search